4Straus SE, Majumdar SR, Mcalister FA. NeW evidence for stroke prevention:clinical applications [J]. JAMA, 2002, 288 (11):1396-1398.
5CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirsus aspirin in patients at risk of ischaemic events (CAPRIE) [J]. Lancet, 1996, 348 (9038): 1329-1339.
6Byington RP, Davis BR, Plehn JF, et al. Reduction of stroke events with pravastatin: the prospective pravastatin pooling (PPP) project[J]. Circulation, 2001, 103(3): 387-392.
7Staessen JA, Wang JG, Thijs L. Cardiovascular protection and blood pressure reduction: a meta-analysis [J]. Lancet, 2001, 358(9290): 1305-1315.
8Collins R, MacMahon S. Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease [J].Br Med Bull, 1994, 50(2): 272-298.
9Klungel OH, Stricker BH, Paes AH, et al. Excess stroke among hypertensive men and women attributable to undertreatment of hypertension[J]. Stroke, 1999, 30(7): 1312-1318.
10ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcum channel blocker vs eiuretic: The Antihypertensive and Lipid-Lowering Treatment to prevent Heat Attack Trial(ALLHAT)[J]. JAMA, 2002, 288(23): 2981-2997.
